CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −100 | $158.18 | $16K | 17,486 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −100 | $162.05 | $16K | 17,386 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −600 | $163.71 | $98K | 16,786 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −1,226 | $164.74 | $202K | 15,560 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −908 | $165.71 | $150K | 14,652 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −1,466 | $166.77 | $244K | 13,186 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −1,500 | $167.72 | $252K | 11,686 |
| 2026-11-03 | MORROW GEORGE J Director | Sale 10b5-1 | −1,300 | $168.53 | $219K | 10,386 |
| 2026-11-02 | MORROW GEORGE J Director | Sale 10b5-1 | −1,900 | $144.98 | $275K | 15,986 |
| 2026-11-02 | MORROW GEORGE J Director | Sale 10b5-1 | −4,300 | $145.86 | $627K | 11,686 |
| 2026-11-02 | MORROW GEORGE J Director | Sale 10b5-1 | −1,300 | $146.76 | $191K | 10,386 |
| 2026-10-30 | MORROW GEORGE J Director | Sale 10b5-1 | −300 | $149.00 | $45K | 10,386 |
| 2026-09-14 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −826 | $157.45 | $130K | 8,722 |
| 2026-09-14 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −2,311 | $157.20 | $363K | 42,808 |
| 2026-09-09 | BENEVICH ERIC Chief Commercial Officer | Sale 10b5-1 | −2,154 | $154.61 | $333K | 64,408 |
| 2026-07-28 | Norwalk Leslie V Director | Sale 10b5-1 | −1,250 | $182.01 | $228K | 1,588 |
| 2026-07-10 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −4,367 | $181.02 | $791K | 16,225 |
| 2026-07-09 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −10,000 | $179.60 | $1.8M | 54,729 |
| 2026-07-09 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −8,433 | $178.72 | $1.5M | 16,225 |
| 2026-07-08 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −2,737 | $178.54 | $489K | 16,225 |
Page 1 of 15 · 294 trades